facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Elevated Impurity > GSMS Incorporated Losartan Potassium 25 Mg And 100 Mg Tablets USP

Recall: GSMS Incorporated Losartan Potassium 25 Mg And 100 Mg Tablets USP


On 2019-04-26, the FDA announced that Teva Pharmaceuticals USA is conducting a recall on Losartan Potassium 25 Mg And 100 Mg Tablets USP due to a possible . The recalled products were sold under the brand name(s) GSMS Incorporated during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 10 drugs recalls due to potential elevated impurity, including losartan potassium usp, losartan potassium tablets, usp, 25mg, 50mg, and 100mg and more. Additionally, there have been 19 drug and medical device recalls due to other health hazards as well as 80 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These

Losartan Potassium, Tablets, USP, 25 mg, 30 Count Bottle, Label
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Teva Pharmaceuticals USA
Phone: 888-838-2872

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information

Regions Where Sold: Nationwide

Product Description: Losartan Potassium 25 mg and 100 mg Tablets USP

Brand Name(s): GSMS Incorporated

Reason for Recall: N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity

Official Recall Date: 2019-04-26


Additional information provided by the

Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). This recall is due to the detection of an impurity - N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) - found in six lots of active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited that is above the US Food & Drug Administration's interim acceptable exposure limit of 9.82 ppm. Based on the available information, the risk of developing cancer in a few patients following long-term use of the product cannot be ruled out. Read More.

More information may be available at

Latest Safety Recalls

Select image for details, including additional styles.




Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top

Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Product Recall Statistics